 Holly Wyatt
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Loss | 53 | 2025 | 867 | 4.510 |
Why?
| | Obesity | 65 | 2025 | 3149 | 3.450 |
Why?
| | Overweight | 17 | 2025 | 617 | 1.640 |
Why?
| | Exercise | 25 | 2025 | 2219 | 1.470 |
Why?
| | Motor Activity | 13 | 2014 | 719 | 1.280 |
Why?
| | Energy Intake | 17 | 2023 | 514 | 1.090 |
Why?
| | Diet, Fat-Restricted | 12 | 2018 | 79 | 1.060 |
Why?
| | Diet, Carbohydrate-Restricted | 10 | 2025 | 38 | 1.010 |
Why?
| | Health Promotion | 7 | 2013 | 792 | 0.790 |
Why?
| | Behavior Therapy | 6 | 2019 | 297 | 0.780 |
Why?
| | Body Weight | 10 | 2019 | 976 | 0.770 |
Why?
| | Weight Gain | 17 | 2013 | 566 | 0.700 |
Why?
| | Life Style | 15 | 2025 | 504 | 0.660 |
Why?
| | Health Behavior | 9 | 2018 | 799 | 0.650 |
Why?
| | Diet, Reducing | 8 | 2025 | 91 | 0.620 |
Why?
| | Energy Metabolism | 11 | 2019 | 937 | 0.620 |
Why?
| | Diet | 12 | 2024 | 1284 | 0.600 |
Why?
| | Monitoring, Ambulatory | 4 | 2010 | 89 | 0.590 |
Why?
| | Body Mass Index | 25 | 2025 | 2470 | 0.530 |
Why?
| | Weight Reduction Programs | 6 | 2019 | 141 | 0.530 |
Why?
| | Registries | 9 | 2022 | 2434 | 0.450 |
Why?
| | Risk Reduction Behavior | 2 | 2015 | 221 | 0.450 |
Why?
| | Mental Health | 1 | 2022 | 813 | 0.440 |
Why?
| | Cardiovascular Diseases | 8 | 2023 | 2218 | 0.440 |
Why?
| | Television | 2 | 2013 | 72 | 0.420 |
Why?
| | Hydrogels | 3 | 2025 | 706 | 0.400 |
Why?
| | Middle Aged | 52 | 2025 | 36821 | 0.400 |
Why?
| | Dietary Proteins | 3 | 2023 | 135 | 0.390 |
Why?
| | Feeding Behavior | 6 | 2013 | 693 | 0.380 |
Why?
| | Adult | 53 | 2025 | 41406 | 0.380 |
Why?
| | Internet | 4 | 2023 | 696 | 0.370 |
Why?
| | Survivors | 2 | 2016 | 528 | 0.360 |
Why?
| | Endocrinology | 1 | 2013 | 77 | 0.350 |
Why?
| | Humans | 85 | 2025 | 147306 | 0.340 |
Why?
| | Walking | 7 | 2011 | 549 | 0.340 |
Why?
| | Cause of Death | 1 | 2013 | 475 | 0.340 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2023 | 2627 | 0.320 |
Why?
| | Female | 60 | 2025 | 80081 | 0.310 |
Why?
| | Male | 59 | 2025 | 73954 | 0.300 |
Why?
| | Dietary Carbohydrates | 5 | 2024 | 147 | 0.290 |
Why?
| | Thinness | 1 | 2009 | 100 | 0.290 |
Why?
| | Disease Outbreaks | 2 | 2009 | 420 | 0.280 |
Why?
| | Dietary Fats | 5 | 2013 | 309 | 0.270 |
Why?
| | Breast Neoplasms | 3 | 2016 | 2420 | 0.270 |
Why?
| | Dairy Products | 1 | 2008 | 30 | 0.260 |
Why?
| | Community Participation | 1 | 2008 | 128 | 0.240 |
Why?
| | Quality of Life | 7 | 2025 | 3246 | 0.240 |
Why?
| | Beverages | 3 | 2015 | 68 | 0.230 |
Why?
| | Anti-Obesity Agents | 3 | 2013 | 67 | 0.230 |
Why?
| | Waist Circumference | 2 | 2024 | 146 | 0.230 |
Why?
| | Non-Nutritive Sweeteners | 2 | 2015 | 7 | 0.220 |
Why?
| | Dietetics | 1 | 2005 | 24 | 0.220 |
Why?
| | Blood Glucose | 4 | 2025 | 2359 | 0.220 |
Why?
| | Hormones | 2 | 2009 | 136 | 0.210 |
Why?
| | Basal Metabolism | 2 | 2018 | 59 | 0.210 |
Why?
| | Social Support | 2 | 2024 | 655 | 0.210 |
Why?
| | Kidney | 1 | 2012 | 1511 | 0.210 |
Why?
| | Appetite Depressants | 1 | 2004 | 19 | 0.200 |
Why?
| | Spouses | 1 | 2024 | 109 | 0.190 |
Why?
| | Primary Prevention | 1 | 2005 | 228 | 0.190 |
Why?
| | Exercise Therapy | 3 | 2012 | 489 | 0.190 |
Why?
| | Health Status | 4 | 2022 | 839 | 0.190 |
Why?
| | Adiposity | 4 | 2023 | 533 | 0.180 |
Why?
| | Blood Pressure | 4 | 2024 | 1785 | 0.180 |
Why?
| | Prediabetic State | 1 | 2025 | 251 | 0.180 |
Why?
| | Prevalence | 10 | 2014 | 2889 | 0.180 |
Why?
| | United States | 16 | 2015 | 16313 | 0.180 |
Why?
| | Time Factors | 8 | 2019 | 7173 | 0.170 |
Why?
| | Washington | 1 | 2022 | 157 | 0.170 |
Why?
| | Counseling | 3 | 2015 | 407 | 0.170 |
Why?
| | Patient Satisfaction | 3 | 2018 | 718 | 0.170 |
Why?
| | Caloric Restriction | 4 | 2025 | 133 | 0.170 |
Why?
| | Capsules | 3 | 2025 | 42 | 0.170 |
Why?
| | Biology | 1 | 2022 | 89 | 0.170 |
Why?
| | Food | 1 | 2002 | 150 | 0.160 |
Why?
| | Aged | 21 | 2025 | 26516 | 0.160 |
Why?
| | DNA Repair | 1 | 2003 | 256 | 0.160 |
Why?
| | Physical Exertion | 3 | 2011 | 205 | 0.160 |
Why?
| | Treatment Outcome | 12 | 2025 | 11947 | 0.160 |
Why?
| | Risk Factors | 13 | 2015 | 11017 | 0.150 |
Why?
| | Contraceptive Agents | 1 | 2020 | 66 | 0.150 |
Why?
| | Telomere | 1 | 2003 | 299 | 0.150 |
Why?
| | Cancer Survivors | 1 | 2024 | 347 | 0.140 |
Why?
| | Body Weight Maintenance | 1 | 2018 | 18 | 0.140 |
Why?
| | Diet, High-Protein | 1 | 2018 | 1 | 0.140 |
Why?
| | Saccharomyces cerevisiae | 1 | 2003 | 585 | 0.140 |
Why?
| | Rest | 1 | 2018 | 127 | 0.130 |
Why?
| | Double-Blind Method | 4 | 2025 | 2080 | 0.130 |
Why?
| | Meat | 1 | 2018 | 64 | 0.130 |
Why?
| | Self Report | 2 | 2013 | 887 | 0.130 |
Why?
| | Histones | 1 | 2003 | 672 | 0.130 |
Why?
| | Self-Control | 1 | 2018 | 56 | 0.130 |
Why?
| | Comorbidity | 4 | 2016 | 1672 | 0.120 |
Why?
| | Fasting | 1 | 2018 | 280 | 0.120 |
Why?
| | Health Surveys | 6 | 2008 | 522 | 0.120 |
Why?
| | Parent-Child Relations | 2 | 2011 | 272 | 0.120 |
Why?
| | Models, Psychological | 1 | 2018 | 295 | 0.120 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 568 | 0.120 |
Why?
| | Eating | 3 | 2013 | 387 | 0.120 |
Why?
| | Prospective Studies | 8 | 2025 | 8166 | 0.110 |
Why?
| | Food Preferences | 2 | 2018 | 126 | 0.110 |
Why?
| | Edible Grain | 2 | 2006 | 47 | 0.100 |
Why?
| | Sweetening Agents | 1 | 2014 | 57 | 0.100 |
Why?
| | Metabolic Syndrome | 2 | 2007 | 365 | 0.100 |
Why?
| | Executive Function | 1 | 2018 | 472 | 0.090 |
Why?
| | Drinking Water | 1 | 2014 | 90 | 0.090 |
Why?
| | Bupropion | 1 | 2013 | 48 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 353 | 0.090 |
Why?
| | Recurrence | 2 | 2013 | 1151 | 0.090 |
Why?
| | Endothelium | 1 | 2013 | 119 | 0.090 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 70 | 0.090 |
Why?
| | Water | 1 | 2015 | 452 | 0.090 |
Why?
| | Nutrition Surveys | 2 | 2014 | 279 | 0.090 |
Why?
| | Adolescent | 13 | 2019 | 22826 | 0.090 |
Why?
| | Accelerometry | 1 | 2013 | 126 | 0.090 |
Why?
| | Primary Health Care | 1 | 2002 | 1760 | 0.090 |
Why?
| | Kidney Function Tests | 1 | 2012 | 156 | 0.090 |
Why?
| | Naltrexone | 1 | 2013 | 115 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 31 | 0.080 |
Why?
| | Insulin | 3 | 2018 | 2526 | 0.080 |
Why?
| | Body Composition | 3 | 2023 | 694 | 0.080 |
Why?
| | Appetite | 1 | 2011 | 80 | 0.080 |
Why?
| | Epidemics | 1 | 2011 | 96 | 0.080 |
Why?
| | Family Health | 2 | 2007 | 195 | 0.070 |
Why?
| | Nutritional Requirements | 1 | 2009 | 78 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2010 | 154 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2010 | 253 | 0.070 |
Why?
| | Adipose Tissue | 2 | 2011 | 646 | 0.070 |
Why?
| | Hypercholesterolemia | 1 | 2010 | 95 | 0.070 |
Why?
| | Bariatric Surgery | 1 | 2013 | 258 | 0.070 |
Why?
| | Neoplasms | 2 | 2024 | 2946 | 0.070 |
Why?
| | Young Adult | 7 | 2019 | 14437 | 0.070 |
Why?
| | Cattle | 2 | 2023 | 948 | 0.070 |
Why?
| | Carotid Arteries | 1 | 2009 | 208 | 0.070 |
Why?
| | Public Health | 2 | 2011 | 577 | 0.070 |
Why?
| | Lythraceae | 1 | 2007 | 3 | 0.070 |
Why?
| | Family | 1 | 2013 | 690 | 0.070 |
Why?
| | Hydrolyzable Tannins | 1 | 2007 | 6 | 0.070 |
Why?
| | Sick Leave | 1 | 2007 | 16 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2011 | 1342 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2009 | 347 | 0.070 |
Why?
| | New York | 1 | 2008 | 128 | 0.070 |
Why?
| | Coronary Disease | 2 | 2007 | 382 | 0.060 |
Why?
| | Dietary Sucrose | 1 | 2007 | 50 | 0.060 |
Why?
| | Animals | 8 | 2023 | 38417 | 0.060 |
Why?
| | Aged, 80 and over | 6 | 2009 | 8432 | 0.060 |
Why?
| | Efficiency | 1 | 2007 | 103 | 0.060 |
Why?
| | Cholesterol, LDL | 2 | 2024 | 363 | 0.060 |
Why?
| | Patient Compliance | 2 | 2018 | 591 | 0.060 |
Why?
| | Triglycerides | 4 | 2013 | 529 | 0.060 |
Why?
| | Child | 7 | 2013 | 22980 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 1431 | 0.060 |
Why?
| | Regression Analysis | 2 | 2007 | 1003 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3660 | 0.060 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 546 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 1166 | 0.060 |
Why?
| | Metabolic Diseases | 1 | 2007 | 114 | 0.060 |
Why?
| | Physical Fitness | 1 | 2007 | 209 | 0.060 |
Why?
| | Calorimetry, Indirect | 2 | 2018 | 72 | 0.060 |
Why?
| | Patient Education as Topic | 2 | 2007 | 781 | 0.060 |
Why?
| | Coronary Artery Bypass | 1 | 2007 | 269 | 0.050 |
Why?
| | Marital Status | 1 | 2005 | 47 | 0.050 |
Why?
| | Cost of Illness | 1 | 2007 | 327 | 0.050 |
Why?
| | Analysis of Variance | 4 | 2011 | 1302 | 0.050 |
Why?
| | Interviews as Topic | 2 | 2007 | 932 | 0.050 |
Why?
| | Heart Ventricles | 1 | 2009 | 767 | 0.050 |
Why?
| | Cross-Sectional Studies | 5 | 2014 | 6011 | 0.050 |
Why?
| | Computer Simulation | 1 | 2009 | 1018 | 0.050 |
Why?
| | Health Care Costs | 1 | 2007 | 428 | 0.050 |
Why?
| | Cyclobutanes | 1 | 2004 | 7 | 0.050 |
Why?
| | Body Size | 1 | 2024 | 90 | 0.050 |
Why?
| | Colorado | 4 | 2007 | 4591 | 0.050 |
Why?
| | Patient Participation | 1 | 2007 | 449 | 0.050 |
Why?
| | Rats, Wistar | 3 | 2011 | 450 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2005 | 225 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2024 | 296 | 0.050 |
Why?
| | Lactones | 1 | 2004 | 59 | 0.050 |
Why?
| | Diabetic Angiopathies | 1 | 2005 | 267 | 0.050 |
Why?
| | Dietary Supplements | 1 | 2007 | 586 | 0.050 |
Why?
| | Program Evaluation | 1 | 2007 | 952 | 0.050 |
Why?
| | Body Constitution | 1 | 2002 | 51 | 0.050 |
Why?
| | Lipoproteins | 3 | 2010 | 166 | 0.050 |
Why?
| | Rural Population | 1 | 2008 | 685 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 852 | 0.050 |
Why?
| | Acetylation | 1 | 2003 | 262 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 874 | 0.040 |
Why?
| | Leisure Activities | 1 | 2002 | 31 | 0.040 |
Why?
| | Educational Status | 3 | 2012 | 475 | 0.040 |
Why?
| | Bleomycin | 1 | 2003 | 256 | 0.040 |
Why?
| | Fruit | 1 | 2002 | 146 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 423 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1777 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 126 | 0.040 |
Why?
| | DNA Damage | 1 | 2003 | 440 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2018 | 5478 | 0.040 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 75 | 0.040 |
Why?
| | Phosphorylation | 1 | 2003 | 1721 | 0.040 |
Why?
| | Cluster Analysis | 2 | 2012 | 502 | 0.030 |
Why?
| | Mathematical Concepts | 1 | 2018 | 35 | 0.030 |
Why?
| | Portion Size | 1 | 2018 | 6 | 0.030 |
Why?
| | Thermogenesis | 1 | 2018 | 45 | 0.030 |
Why?
| | Leptin | 2 | 2013 | 249 | 0.030 |
Why?
| | Parents | 1 | 2007 | 1428 | 0.030 |
Why?
| | Telemedicine | 1 | 2007 | 978 | 0.030 |
Why?
| | Hunger | 1 | 2018 | 56 | 0.030 |
Why?
| | Craving | 1 | 2018 | 42 | 0.030 |
Why?
| | Motivation | 1 | 2002 | 616 | 0.030 |
Why?
| | Patient Dropouts | 1 | 2018 | 67 | 0.030 |
Why?
| | Child, Preschool | 2 | 2011 | 12017 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2002 | 625 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 654 | 0.030 |
Why?
| | Age Factors | 1 | 2005 | 3372 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2019 | 258 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1379 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 3029 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2005 | 1107 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1281 | 0.030 |
Why?
| | Rats | 3 | 2011 | 5613 | 0.030 |
Why?
| | Models, Biological | 2 | 2018 | 1772 | 0.030 |
Why?
| | Lipid Metabolism | 2 | 2011 | 538 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2012 | 6164 | 0.030 |
Why?
| | Precision Medicine | 1 | 2018 | 464 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2133 | 0.020 |
Why?
| | Circadian Rhythm | 2 | 2009 | 514 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2024 | 17561 | 0.020 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2013 | 59 | 0.020 |
Why?
| | Nausea | 1 | 2013 | 112 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2013 | 191 | 0.020 |
Why?
| | Psychotherapy, Group | 1 | 2012 | 79 | 0.020 |
Why?
| | Hypertension | 2 | 2013 | 1280 | 0.020 |
Why?
| | Brachial Artery | 1 | 2013 | 209 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 185 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 779 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 210 | 0.020 |
Why?
| | Ketone Bodies | 1 | 2010 | 16 | 0.020 |
Why?
| | Switzerland | 1 | 2010 | 46 | 0.020 |
Why?
| | Japan | 1 | 2010 | 149 | 0.020 |
Why?
| | Behavior, Addictive | 1 | 2011 | 89 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1046 | 0.020 |
Why?
| | Tunica Media | 1 | 2009 | 38 | 0.020 |
Why?
| | Social Environment | 1 | 2011 | 254 | 0.020 |
Why?
| | Tunica Intima | 1 | 2009 | 79 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 522 | 0.020 |
Why?
| | Australia | 1 | 2010 | 299 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2011 | 4605 | 0.020 |
Why?
| | Diastole | 1 | 2009 | 147 | 0.020 |
Why?
| | Systole | 1 | 2009 | 181 | 0.020 |
Why?
| | Photoperiod | 1 | 2009 | 55 | 0.020 |
Why?
| | Socioenvironmental Therapy | 1 | 2009 | 2 | 0.020 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 124 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2009 | 202 | 0.020 |
Why?
| | Attitude to Health | 1 | 2012 | 431 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2013 | 794 | 0.020 |
Why?
| | Satiety Response | 1 | 2008 | 11 | 0.020 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2007 | 29 | 0.020 |
Why?
| | Polyphenols | 1 | 2007 | 21 | 0.020 |
Why?
| | Adipocytes | 1 | 2009 | 223 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 1077 | 0.020 |
Why?
| | Ventricular Remodeling | 1 | 2009 | 283 | 0.020 |
Why?
| | Flavonoids | 1 | 2007 | 85 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 4354 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2007 | 120 | 0.020 |
Why?
| | Phenols | 1 | 2007 | 106 | 0.020 |
Why?
| | Demography | 1 | 2007 | 283 | 0.020 |
Why?
| | Echocardiography | 1 | 2009 | 652 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2007 | 80 | 0.010 |
Why?
| | Bone Density | 1 | 2010 | 493 | 0.010 |
Why?
| | Exercise Test | 1 | 2009 | 636 | 0.010 |
Why?
| | Nutrition Assessment | 1 | 2006 | 91 | 0.010 |
Why?
| | Health Expenditures | 1 | 2007 | 199 | 0.010 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 59 | 0.010 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2006 | 106 | 0.010 |
Why?
| | Employment | 1 | 2007 | 184 | 0.010 |
Why?
| | Interpersonal Relations | 1 | 2009 | 403 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2008 | 617 | 0.010 |
Why?
| | Homeostasis | 1 | 2009 | 651 | 0.010 |
Why?
| | Sex Factors | 1 | 2011 | 2136 | 0.010 |
Why?
| | Insurance, Health | 1 | 2007 | 321 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1550 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 550 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2030 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3448 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2625 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1798 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 1024 | 0.010 |
Why?
| | Pediatrics | 1 | 2007 | 1139 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 1051 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2007 | 3022 | 0.010 |
Why?
|
|
Wyatt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|